Industry Relationships
Ownership or Investment Interest
Faculty member and/or their immediate family have an ownership or investment interest in the following companies
- BioFluid Technology, Inc.
- Genome Foundry
- Ikaika Therapeutics
- Isobatic Technology Systems
- Kardigan
- Oligo Foundry
- OncoSenescence, LLC
- Phrixus Pharmaceuticals, Inc.
- Riptide Bioscience, Inc
Consulting
Faculty member and/or their immediate family have engaged in activities such as speaking, advising, consulting, or providing educational programs for the following companies or other entities
- American Society for Clinical Investigation, Inc.
- National Institutes of Health (NIH)
- PepGen Inc
- Tenaya Therapeutics
- University of Washington School of Medicine
Royalties
Faculty member and/or their immediate family have the right to receive payments or may receive future financial benefits for inventions or discoveries related to the following companies or other entities
- Ikaika Therapeutics
- University of Chicago
Board of Directors
Faculty member and/or their immediate family served in a fiduciary capacity, such as a board member/director, officer, or trustee, for the following companies or other entities
- American Society for Clinical Investigation, Inc.
- Ikaika Therapeutics
- Muscular Dystrophy Association (MDA)
External Professional Relationships
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.